Hasil Pencarian - Halina Offner
- Menampilkan 1 - 12 hasil dari 12
-
1
-
2
Novel therapeutic for multiple sclerosis protects white matter function in EAE mouse model oleh Sarah Zerimech, Hung Nguyen, Arthur A. Vandenbark, Arthur A. Vandenbark, Arthur A. Vandenbark, Halina Offner, Halina Offner, Halina Offner, Selva Baltan
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel -
3
The splenic response to stroke: from rodents to stroke subjects oleh Hilary A. Seifert, Halina Offner
Diterbitkan 2018-07-01Dapatkan teks lengkap
Artikel -
4
Microglia and astrocyte involvement in neurodegeneration and brain cancer oleh Arthur A. Vandenbark, Halina Offner, Szymon Matejuk, Agata Matejuk
Diterbitkan 2021-12-01Dapatkan teks lengkap
Artikel -
5
-
6
Estrogen-induced compensatory mechanisms protect IL-10-deficient mice from developing EAE oleh Hilary A. Seifert, Grant Gerstner, Gail Kent, Arthur A. Vandenbark, Halina Offner
Diterbitkan 2019-10-01Dapatkan teks lengkap
Artikel -
7
MIF contribution to progressive brain diseases oleh Agata Matejuk, Gil Benedek, Richard Bucala, Szymon Matejuk, Halina Offner, Arthur A. Vandenbark
Diterbitkan 2024-01-01Dapatkan teks lengkap
Artikel -
8
Major histocompatibility complex Class II-based therapy for stroke oleh Bella M Gonzales-Portillo, Jea-Young Lee, Arthur A Vandenbark, Halina Offner, Cesario V Borlongan
Diterbitkan 2021-01-01Dapatkan teks lengkap
Artikel -
9
RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS. oleh Sushmita Sinha, Lisa M Miller, Sandhya Subramanian, Gregory G Burrows, Arthur A Vandenbark, Halina Offner
Diterbitkan 2011-01-01Dapatkan teks lengkap
Artikel -
10
-
11
5-Androstenediol Ameliorates Pleurisy, Septic Shock, and Experimental Autoimmune Encephalomyelitis in Mice oleh Ferdinando Nicoletti, Dominick L. Auci, Katia Mangano, Jaime Flores-Riveros, Sonia Villegas, James M. Frincke, Christopher L. Reading, Halina Offner
Diterbitkan 2010-01-01Dapatkan teks lengkap
Artikel -
12
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study oleh Vijayshree Yadav, Dennis N. Bourdette, James D. Bowen, Sharon G. Lynch, David Mattson, Jana Preiningerova, Christopher T. Bever, Jack Simon, Andrew Goldstein, Gregory G. Burrows, Halina Offner, Al J. Ferro, Arthur A. Vandenbark
Diterbitkan 2012-01-01Dapatkan teks lengkap
Artikel